. 2014 Sep 4;149(1):R15–R33. doi: 10.1530/REP-14-0416
This work is licensed under a Table 1.
Current active interventional clinical trials using antiprogestins for gynecological diseases registered in ClinicalTrials.gov a .
| Antiprogestin | Gynecological disease | Phase | Clinical trial ID |
|---|---|---|---|
| Mifepristone (RU-38486) | Leiomyoma | III | NCT00133705 |
| I | NCT00579475 | ||
| II | NCT00881140 | ||
| II/III | NCT00712595 | ||
| Breast cancer | I | NCT01493310 | |
| II | NCT01898312 | ||
| Breast and ovarian cancers | I | NCT02046421 | |
| I | NCT02014337 | ||
| Endometrial cancer | II | NCT00505739 | |
| Ulipristal (CDB-2914) | Leiomyoma | II | NCT00044876 |
| III | NCT02147158 | ||
| III | NCT01642472 | ||
| III | NCT01629563 | ||
| Telapristone (CDB-4124) | Endometriosis | II | NCT01728454 |
| Breast cancer | II | NCT01800422 | |
| Onapristone (ZK-98299) | PR expressing cancers | I | NCT02052158 |
a
Data obtained August 5, 2014.